Intellipharmaceutics International (NASDAQ: IPCI) entered into an agreement with Teva Pharmaceuticals USA, Inc. (NASDAQ: TEVA) by which the Company has ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE